Boston Scientific (BSX) Receives FDA Approval of Two Rhythmia-Related Catheters

May 3, 2016 4:37 PM EDT Send to a Friend
Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for two catheters that can be used ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login